TreeWAS – Variant ID: rs116320373

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Showing all nodes without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability
Chapter II Neoplasms	1.000	0.000
# Top node	1.000	0.000
C76-C80 Malignant neoplasms of ill-defined, secondary and unspecified sites	0.998	0.002
C77 Secondary and unspecified malignant neoplasm of lymph nodes	0.996	0.004
Chapter XIII Diseases of the musculoskeletal system and connective tissue	0.996	0.004
D10-D36 Benign neoplasms	0.992	0.008
Chapter XXI Factors influencing health status and contact with health services	0.992	0.008
Chapter I Certain infectious and parasitic diseases	0.991	0.009
Chapter XIV Diseases of the genitourinary system	0.990	0.010
M20-M25 Other joint disorders	0.986	0.014
Z40-Z54 Persons encountering health services for specific procedures and health care	0.986	0.014
Chapter XX External causes of morbidity and mortality	0.986	0.014
C81-C96 Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue	0.982	0.018
A00-A09 Intestinal infectious diseases	0.975	0.025
C50-C50 Malignant neoplasm of breast	0.975	0.025
N17-N19 Renal failure	0.973	0.027
D17 Benign lipomatous neoplasm	0.966	0.034
A09 Diarrhoea and gastro-enteritis of presumed infectious origin	0.965	0.035
Z51 Other medical care	0.964	0.036
Chapter XIX Injury, poisoning and certain other consequences of external causes	0.962	0.038
A09.9 Gastroenteritis and colitis of unspecified origin	0.958	0.042
C50 Malignant neoplasm of breast	0.957	0.043
N18 Chronic renal failure	0.954	0.046
M65-M68 Disorders of synovium and tendon	0.954	0.046
Y85-Y89 Sequelae of external causes of morbidity and mortality	0.953	0.047
C50.9 Breast, unspecified	0.952	0.048
C77.1 Intrathoracic lymph nodes	0.950	0.050
M23 Internal derangement of knee	0.949	0.051
D00-D09 In situ neoplasms	0.947	0.053
C77.0 Lymph nodes of head, face and neck	0.946	0.054
D17.2 Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs	0.944	0.056
D24 Benign neoplasm of breast	0.941	0.059
D37-D48 Neoplasms of uncertain or unknown behaviour	0.940	0.060
N00-N08 Glomerular diseases	0.933	0.067
Z51.3 Blood transfusion without reported diagnosis	0.930	0.070
N40-N51 Diseases of male genital organs	0.930	0.070
Chapter XVII Congenital malformations, deformations and chromosomal abnormalities	0.927	0.073
Chapter IV Endocrine, nutritional and metabolic diseases	0.921	0.079
N18.3 Chronic kidney disease, stage 3	0.920	0.080
Z45 Adjustment and management of implanted device	0.918	0.082
C64-C68 Malignant neoplasms of urinary tract	0.913	0.087
Y40-Y59 Drugs, medicaments and biological substances causing adverse effects in therapeutic use	0.911	0.089
M20 Acquired deformities of fingers and toes	0.911	0.089
C77.2 Intra-abdominal lymph nodes	0.910	0.090
M65 Synovitis and tenosynovitis	0.902	0.098
Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism	0.902	0.098
E70-E90 Metabolic disorders	0.901	0.099
Y86 Sequelae of other accidents	0.899	0.101
C79 Secondary malignant neoplasm of other sites	0.899	0.101
N41 Inflammatory diseases of prostate	0.890	0.110
M23.8 Other internal derangements of knee	0.889	0.111
M95-M99 Other disorders of the musculoskeletal system and connective tissue	0.885	0.115
T80-T88 Complications of surgical and medical care, not elsewhere classified	0.883	0.117
S30-S39 Injuries to the abdomen, lower back, lumbar spine and pelvis	0.881	0.119
Z50 Care involving use of rehabilitation procedures	0.878	0.122
Z45.2 Adjustment and management of vascular access device	0.871	0.129
A30-A49 Other bacterial diseases	0.868	0.132
D17.6 Benign lipomatous neoplasm of spermatic cord	0.866	0.134
Z70-Z76 Persons encountering health services in other circumstances	0.864	0.136
N25-N29 Other disorders of kidney and ureter	0.864	0.136
M23.81 Other internal derangements of knee (Anterior cruciate ligament or Anterior horn of medial meniscus)	0.860	0.140
S20-S29 Injuries to the thorax	0.856	0.144
M65.9 Synovitis and tenosynovitis, unspecified	0.855	0.145
C51-C58 Malignant neoplasms of female genital organs	0.849	0.151
Z80-Z99 Persons with potential health hazards related to family and personal history and certain conditions influencing health status	0.849	0.151
C83 Diffuse non-Hodgkin's lymphoma	0.848	0.152
N43 Hydrocele and spermatocele	0.848	0.152
E83 Disorders of mineral metabolism	0.847	0.153
Z85 Personal history of malignant neoplasm	0.847	0.153
M23.2 Derangement of meniscus due to old tear or injury	0.845	0.155
Z51.8 Other specified medical care	0.844	0.156
Z85.3 Personal history of malignant neoplasm of breast	0.844	0.156
M80-M85 Disorders of bone density and structure	0.843	0.157
Y90-Y98 Supplementary factors related to causes of morbidity and mortality classified elsewhere	0.842	0.158
T90-T98 Sequelae of injuries, of poisoning and of other consequences of external causes	0.840	0.160
B25-B34 Other viral diseases	0.840	0.160
C81 Hodgkin's disease	0.839	0.161
Y85 Sequelae of transport accidents	0.838	0.162
N17 Acute renal failure	0.837	0.163
N41.1 Chronic prostatitis	0.837	0.163
Q60-Q64 Congenital malformations of the urinary system	0.835	0.165
C90 Multiple myeloma and malignant plasma cell neoplasms	0.830	0.170
N03 Chronic nephritic syndrome	0.828	0.172
N02 Recurrent and persistent haematuria	0.827	0.173
D18 Haemangioma and lymphangioma, any site	0.825	0.175
C67 Malignant neoplasm of bladder	0.822	0.178
M20.1 Hallux valgus (acquired)	0.821	0.179
M22 Disorders of patella	0.818	0.182
Y43 Primarily systemic agents	0.817	0.183
Chapter XXII Codes for special purposes	0.816	0.184
C69-C72 Malignant neoplasms of eye, brain and other parts of central nervous system	0.816	0.184
M65.96 Synovitis and tenosynovitis, unspecified (Lower leg)	0.813	0.187
D05 Carcinoma in situ of breast	0.811	0.189
D04 Carcinoma in situ of skin	0.809	0.191
E83.5 Disorders of calcium metabolism	0.808	0.192
C80 Malignant neoplasm without specification of site	0.806	0.194
T82 Complications of cardiac and vascular prosthetic devices, implants and grafts	0.805	0.195
E86 Volume depletion	0.805	0.195
Z45.1 Adjustment and management of infusion pump	0.803	0.197
C82 Follicular [nodular] non-Hodgkin's lymphoma	0.802	0.198
C77.3 Axillary and upper limb lymph nodes	0.800	0.200
Z93 Artificial opening status	0.800	0.200
S32 Fracture of lumbar spine and pelvis	0.798	0.202
N42 Other disorders of prostate	0.795	0.205
Z51.4 Preparatory care for treatment, not elsewhere classified	0.794	0.205
Z51.1 Chemotherapy session for neoplasm	0.794	0.206
Z42 Follow-up care involving plastic surgery	0.794	0.206
D38 Neoplasm of uncertain or unknown behaviour of middle ear and respiratory and intrathoracic organs	0.794	0.206
D12 Benign neoplasm of colon, rectum, anus and anal canal	0.793	0.207
Chapter VIII Diseases of the ear and mastoid process	0.793	0.207
D10 Benign neoplasm of mouth and pharynx	0.793	0.207
Z85.5 Personal history of malignant neoplasm of urinary tract	0.793	0.207
D46 Myelodysplastic syndromes	0.792	0.208
N43.3 Hydrocele, unspecified	0.789	0.211
Z92 Personal history of medical treatment	0.789	0.211
D41 Neoplasm of uncertain or unknown behaviour of urinary organs	0.786	0.214
C50.3 Lower-inner quadrant of breast	0.784	0.216
D23 Other benign neoplasms of skin	0.784	0.216
M96 Postprocedural musculoskeletal disorders, not elsewhere classified	0.783	0.217
M23.23 Derangement of meniscus due to old tear or injury (Medial collateral ligament or Other and unspecified medial meniscus)	0.783	0.217
D37 Neoplasm of uncertain or unknown behaviour of oral cavity and digestive organs	0.781	0.219
C00-C14 Malignant neoplasms of lip, oral cavity and pharynx	0.779	0.221
B90-B94 Sequelae of infectious and parasitic diseases	0.777	0.223
A02 Other Salmonella infections	0.777	0.223
C85 Other and unspecified types of non-Hodgkin's lymphoma	0.775	0.225
D65-D69 Coagulation defects, purpura and other haemorrhagic conditions	0.774	0.226
N28 Other disorders of kidney and ureter, not elsewhere classified	0.774	0.226
Z87 Personal history of other diseases and conditions	0.772	0.228
D07 Carcinoma in situ of other and unspecified genital organs	0.769	0.231
C30-C39 Malignant neoplasms of respiratory and intrathoracic organs	0.769	0.231
Z48 Other surgical follow-up care	0.769	0.231
Q61 Cystic kidney disease	0.769	0.231
A41 Other septicaemia	0.766	0.234
N18.2 Chronic kidney disease, stage 2	0.766	0.234
Z92.6 Personal history of chemotherapy for neoplastic disease	0.766	0.234
B65-B83 Helminthiases	0.766	0.234
C15-C26 Malignant neoplasms of digestive organs	0.764	0.236
E20-E35 Disorders of other endocrine glands	0.763	0.237
C77.9 Lymph node, unspecified	0.763	0.237
Z93.2 Ileostomy status	0.762	0.238
M24 Other specific joint derangements	0.760	0.239
N99-N99 Other disorders of the genitourinary system	0.760	0.240
C92 Myeloid leukaemia	0.759	0.241
M67 Other disorders of synovium and tendon	0.759	0.241
Z54 Convalescence	0.758	0.242
X60-X84 Intentional self-harm	0.757	0.243
D13 Benign neoplasm of other and ill-defined parts of digestive system	0.756	0.244
N18.4 Chronic kidney disease, stage 4	0.756	0.244
T66-T78 Other and unspecified effects of external causes	0.755	0.245
N41.9 Inflammatory disease of prostate, unspecified	0.754	0.245
C83.3 Large cell (diffuse)	0.753	0.247
N03.9 Unspecified	0.753	0.247
T84 Complications of internal orthopaedic prosthetic devices, implants and grafts	0.752	0.248
D17.0 Benign lipomatous neoplasm of skin and subcutaneous tissue of head, face and neck	0.750	0.250
D06 Carcinoma in situ of cervix uteri	0.748	0.251
Z40 Prophylactic surgery	0.748	0.252
E50-E64 Other nutritional deficiencies	0.747	0.253
T88 Other complications of surgical and medical care, not elsewhere classified	0.747	0.253
M31 Other necrotising vasculopathies	0.746	0.254
N18.5 Chronic kidney disease, stage 5	0.745	0.255
H65-H75 Diseases of middle ear and mastoid	0.745	0.255
N02.9 Unspecified	0.744	0.256
Q38-Q45 Other congenital malformations of the digestive system	0.743	0.257
C77.5 Intrapelvic lymph nodes	0.743	0.257
D55-D59 Haemolytic anaemias	0.741	0.259
Y95 Nosocomial condition	0.740	0.260
C79.9 Secondary malignant neoplasm, unspecified site	0.739	0.261
S32.0 Fracture of lumbar vertebra	0.739	0.261
C64 Malignant neoplasm of kidney, except renal pelvis	0.738	0.262
M23.6 Other spontaneous disruption of ligament(s) of knee	0.737	0.262
C81.9 Hodgkin's disease, unspecified	0.737	0.263
C73-C75 Malignant neoplasms of thyroid and other endocrine glands	0.737	0.263
Z75 Problems related to medical facilities and other health care	0.737	0.263
Chapter XV Pregnancy, childbirth and the puerperium	0.737	0.263
D12.6 Colon, unspecified	0.737	0.263
D17.9 Benign lipomatous neoplasm, unspecified	0.736	0.264
M66 Spontaneous rupture of synovium and tendon	0.736	0.264
Z85.2 Personal history of malignant neoplasm of other respiratory and intrathoracic organs	0.736	0.264
Y41 Other systemic anti-infectives and antiparasitics	0.734	0.266
D35 Benign neoplasm of other and unspecified endocrine glands	0.734	0.266
Z49 Care involving dialysis	0.734	0.266
B34 Viral infection of unspecified site	0.732	0.268
T51-T65 Toxic effects of substances chiefly nonmedicinal as to source	0.732	0.268
S10-S19 Injuries to the neck	0.732	0.268
C91 Lymphoid leukaemia	0.731	0.269
S90-S99 Injuries to the ankle and foot	0.731	0.269
Z43 Attention to artificial openings	0.730	0.270
M80 Osteoporosis with pathological fracture	0.728	0.271
T80 Complications following infusion, transfusion and therapeutic injection	0.728	0.272
Z20-Z29 Persons with potential health hazards related to communicable diseases	0.728	0.272
M34 Systemic sclerosis	0.727	0.273
S30 Superficial injury of abdomen, lower back and pelvis	0.725	0.274
D23.1 Skin of eyelid, including canthus	0.725	0.275
Q65-Q79 Congenital malformations and deformations of the musculoskeletal system	0.725	0.275
Y43.3 Other antineoplastic drugs	0.724	0.276
N50 Other disorders of male genital organs	0.724	0.276
M20.5 Other deformities of toe(s) (acquired)	0.723	0.277
Z50.9 Care involving use of rehabilitation procedure, unspecified	0.723	0.277
D32 Benign neoplasm of meninges	0.721	0.278
C90.0 Multiple myeloma	0.721	0.279
V10-V19 Pedal cyclist injured in transport accident	0.720	0.280
E78 Disorders of lipoprotein metabolism and other lipidaemias	0.719	0.281
C79.5 Secondary malignant neoplasm of bone and bone marrow	0.719	0.281
C77.8 Lymph nodes of multiple regions	0.718	0.282
C54 Malignant neoplasm of corpus uteri	0.717	0.283
C97-C97 Malignant neoplasms of independent (primary) multiple sites	0.717	0.283
C45-C49 Malignant neoplasms of mesothelial and soft tissue	0.717	0.283
C40-C41 Malignant neoplasms of bone and articular cartilage	0.717	0.283
Chapter XVI Certain conditions originating in the perinatal period	0.717	0.283
C76 Malignant neoplasm of other and ill-defined sites	0.716	0.284
Z50.7 Occupational therapy and vocational rehabilitation, not elsewhere classified	0.716	0.284
M20.4 Other hammer toe(s) (acquired)	0.715	0.285
D50-D53 Nutritional anaemias	0.715	0.285
D21 Other benign neoplasms of connective and other soft tissue	0.714	0.286
C50.8 Overlapping lesion of breast	0.714	0.286
Q80-Q89 Other congenital malformations	0.714	0.286
M91-M94 Chondropathies	0.714	0.286
M60-M63 Disorders of muscles	0.714	0.286
M00-M03 Infectious arthropathies	0.714	0.286
D05.9 Carcinoma in situ of breast, unspecified	0.714	0.286
M65.8 Other synovitis and tenosynovitis	0.713	0.287
D47 Other neoplasms of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue	0.713	0.287
C79.8 Secondary malignant neoplasm of other specified sites	0.713	0.287
Chapter VI Diseases of the nervous system	0.712	0.288
D31 Benign neoplasm of eye and adnexa	0.711	0.289
D30 Benign neoplasm of urinary organs	0.711	0.289
D29 Benign neoplasm of male genital organs	0.711	0.289
D28 Benign neoplasm of other and unspecified female genital organs	0.711	0.289
D26 Other benign neoplasms of uterus	0.711	0.289
D20 Benign neoplasm of soft tissue of retroperitoneum and peritoneum	0.711	0.289
D19 Benign neoplasm of mesothelial tissue	0.711	0.289
D16 Benign neoplasm of bone and articular cartilage	0.711	0.289
D15 Benign neoplasm of other and unspecified intrathoracic organs	0.711	0.289
D14 Benign neoplasm of middle ear and respiratory system	0.711	0.289
M21 Other acquired deformities of limbs	0.711	0.289
B99-B99 Other infectious diseases	0.710	0.290
B85-B89 Pediculosis, acariasis and other infestations	0.710	0.290
B50-B64 Protozoal diseases	0.710	0.290
B20-B24 Human immunodeficiency virus [HIV] disease	0.710	0.290
A92-A99 Arthropod-borne viral fevers and viral haemorrhagic fevers	0.710	0.290
A80-A89 Viral infections of the central nervous system	0.710	0.290
A75-A79 Rickettsioses	0.710	0.290
A70-A74 Other diseases caused by chlamydiae	0.710	0.290
A65-A69 Other spirochaetal diseases	0.710	0.290
A20-A28 Certain zoonotic bacterial diseases	0.710	0.290
A15-A19 Tuberculosis	0.710	0.290
Z50.4 Psychotherapy, not elsewhere classified	0.709	0.291
M96.0 Pseudarthrosis after fusion or arthrodesis	0.709	0.291
B15-B19 Viral hepatitis	0.708	0.292
A41.5 Septicaemia due to other Gram-negative organisms	0.708	0.292
M20.0 Deformity of finger(s)	0.707	0.292
A50-A64 Infections with a predominantly sexual mode of transmission	0.707	0.293
M35 Other systemic involvement of connective tissue	0.707	0.293
C79.2 Secondary malignant neoplasm of skin	0.707	0.293
M36 Systemic disorders of connective tissue in diseases classified elsewhere	0.707	0.293
M33 Dermatopolymyositis	0.707	0.293
M32 Systemic lupus erythematosus	0.707	0.293
M30 Polyarteritis nodosa and related conditions	0.707	0.293
Y85.9 Sequelae of other and unspecified transport accidents	0.707	0.293
S20 Superficial injury of thorax	0.707	0.293
Z44 Fitting and adjustment of external prosthetic device	0.707	0.293
Y70-Y82 Medical devices associated with adverse incidents in diagnostic and therapeutic use	0.707	0.293
Y35-Y36 Legal intervention and operations of war	0.707	0.293
Y10-Y34 Event of undetermined intent	0.707	0.293
Y00-Y09 Assault	0.707	0.293
X85-X99 Assault	0.707	0.293
X58-X59 Accidental exposure to other and unspecified factors	0.707	0.293
X50-X57 Overexertion, travel and privation	0.707	0.293
X40-X49 Accidental poisoning by and exposure to noxious substances	0.707	0.293
X30-X39 Exposure to forces of nature	0.707	0.293
X20-X29 Contact with venomous animals and plants	0.707	0.293
X10-X19 Contact with heat and hot substances	0.707	0.293
X00-X09 Exposure to smoke, fire and flames	0.707	0.293
W85-W99 Exposure to electric current, radiation and extreme ambient air temperature and pressure	0.707	0.293
W75-W84 Other accidental threats to breathing	0.707	0.293
W65-W74 Accidental drowning and submersion	0.707	0.293
W50-W64 Exposure to animate mechanical forces	0.707	0.293
V98-V99 Other and unspecified transport accidents	0.707	0.293
V95-V97 Air and space transport accidents	0.707	0.293
V90-V94 Water transport accidents	0.707	0.293
V80-V89 Other land transport accidents	0.707	0.293
V70-V79 Bus occupant injured in transport accident	0.707	0.293
V60-V69 Occupant of heavy transport vehicle injured in transport accident	0.707	0.293
V50-V59 Occupant of pick-up truck or van injured in transport accident	0.707	0.293
V40-V49 Car occupant injured in transport accident	0.707	0.293
V30-V39 Occupant of three-wheeled motor vehicle injured in transport accident	0.707	0.293
V20-V29 Motorcycle rider injured in transport accident	0.707	0.293
V01-V09 Pedestrian injured in transport accident	0.707	0.293
M23.4 Loose body in knee	0.706	0.293
C50.0 Nipple and areola	0.706	0.294
N18.9 Chronic renal failure, unspecified	0.706	0.294
T92 Sequelae of injuries of upper limb	0.706	0.294
D18.0 Haemangioma, any site	0.705	0.295
S22 Fracture of rib(s), sternum and thoracic spine	0.705	0.295
C96 Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue	0.704	0.296
C95 Leukaemia of unspecified cell type	0.704	0.296
C94 Other leukaemias of specified cell type	0.704	0.296
C93 Monocytic leukaemia	0.704	0.296
C88 Malignant immunoproliferative diseases	0.704	0.296
C86 Other specified types of T/NK-cell lymphoma	0.704	0.296
C84 Peripheral and cutaneous T-cell lymphomas	0.704	0.296
Y51 Drugs primarily affecting the autonomic nervous system	0.704	0.296
M86-M90 Other osteopathies	0.703	0.297
M50-M54 Other dorsopathies	0.702	0.298
D80-D89 Certain disorders involving the immune mechanism	0.702	0.298
Z93.0 Tracheostomy status	0.701	0.299
N17.9 Acute renal failure, unspecified	0.701	0.299
Z92.4 Personal history of major surgery, not elsewhere classified	0.700	0.300
A07 Other protozoal intestinal diseases	0.699	0.301
A06 Amoebiasis	0.699	0.301
A05 Other bacterial foodborne intoxications	0.699	0.301
A03 Shigellosis	0.699	0.301
A01 Typhoid and paratyphoid fevers	0.699	0.301
A00 Cholera	0.699	0.301
Y40 Systemic antibiotics	0.698	0.302
Z85.7 Personal history of other malignant neoplasms of lymphoid, haematopoietic and related tissues	0.697	0.303
S32.00 Fracture of lumbar vertebra (closed)	0.697	0.303
D25 Leiomyoma of uterus	0.697	0.303
E40-E46 Malnutrition	0.696	0.304
Q61.3 Polycystic kidney, unspecified	0.695	0.305
A46 Erysipelas	0.694	0.306
D17.4 Benign lipomatous neoplasm of intrathoracic organs	0.693	0.307
C67.1 Dome of bladder	0.693	0.307
M95 Other acquired deformities of musculoskeletal system and connective tissue	0.692	0.307
Z51.9 Medical care, unspecified	0.691	0.308
Z51.6 Desensitisation to allergens	0.691	0.308
S70-S79 Injuries to the hip and thigh	0.691	0.309
D11 Benign neoplasm of major salivary glands	0.690	0.310
W00-W19 Falls	0.689	0.310
T33-T35 Frostbite	0.689	0.310
T26-T28 Burns and corrosions confined to eye and internal organs	0.689	0.310
T20-T25 Burns and corrosions of external body surface, specified by site	0.689	0.310
T08-T14 Injuries to unspecified part of trunk, limb or body region	0.689	0.310
T00-T07 Injuries involving multiple body regions	0.689	0.310
D38.1 Trachea, bronchus and lung	0.689	0.311
E83.4 Disorders of magnesium metabolism	0.689	0.311
O94-O99 Other obstetric conditions, not elsewhere classified	0.689	0.311
Z87.0 Personal history of diseases of the respiratory system	0.688	0.312
Y85.0 Sequelae of motor-vehicle accident	0.687	0.313
C50.6 Axillary tail of breast	0.686	0.314
D46.9 Myelodysplastic syndrome, unspecified	0.686	0.314
T79-T79 Certain early complications of trauma	0.685	0.315
M65.94 Synovitis and tenosynovitis, unspecified (Hand)	0.685	0.315
Z50.1 Other physical therapy	0.685	0.315
N18.8 Other chronic renal failure	0.684	0.316
N18.1 Chronic kidney disease, stage 1	0.684	0.316
M23.20 Derangement of meniscus due to old tear or injury (Multiple sites)	0.684	0.316
M68 Disorders of synovium and tendon in diseases classified elsewhere	0.684	0.316
D37.4 Colon	0.684	0.316
Y89 Sequelae of other external causes	0.683	0.317
Y88 Sequelae of surgical and medical care as external cause	0.683	0.317
Y87 Sequelae of intentional self-harm, assault and events of undetermined intent	0.683	0.317
Z71 Persons encountering health services for other counselling and medical advice, not elsewhere classified	0.683	0.317
M23.26 Derangement of meniscus due to old tear or injury (Other and unspecified lateral meniscus)	0.681	0.319
M23.9 Internal derangement of knee, unspecified	0.681	0.319
M23.5 Chronic instability of knee	0.681	0.319
M23.1 Discoid meniscus (congenital)	0.681	0.319
M23.0 Cystic meniscus	0.681	0.319
M23.83 Other internal derangements of knee (Medial collateral ligament or Other and unspecified medial meniscus)	0.681	0.319
Z42.1 Follow-up care involving plastic surgery of breast	0.681	0.319
D12.3 Transverse colon	0.680	0.320
D09 Carcinoma in situ of other and unspecified sites	0.679	0.321
D02 Carcinoma in situ of middle ear and respiratory system	0.679	0.321
D01 Carcinoma in situ of other and unspecified digestive organs	0.679	0.321
D00 Carcinoma in situ of oral cavity, oesophagus and stomach	0.679	0.321
Y44 Agents primarily affecting blood constituents	0.679	0.321
Z48.0 Attention to surgical dressings and sutures	0.678	0.322
T83 Complications of genito-urinary prosthetic devices, implants and grafts	0.678	0.322
N08 Glomerular disorders in diseases classified elsewhere	0.678	0.322
T15-T19 Effects of foreign body entering through natural orifice	0.677	0.323
M22.4 Chondromalacia patellae	0.677	0.323
B00-B09 Viral infections characterized by skin and mucous membrane lesions	0.677	0.323
E78.5 Hyperlipidaemia, unspecified	0.677	0.323
T29-T32 Burns and corrosions of multiple and unspecified body regions	0.676	0.324
N18.0 End-stage renal disease	0.675	0.325
Z89 Acquired absence of limb	0.675	0.325
M20.3 Other deformity of hallux (acquired)	0.675	0.325
D41.4 Bladder	0.675	0.325
T90 Sequelae of injuries of head	0.674	0.326
T82.0 Mechanical complication of heart valve prosthesis	0.674	0.326
D44 Neoplasm of uncertain or unknown behaviour of endocrine glands	0.674	0.326
D43 Neoplasm of uncertain or unknown behaviour of brain and central nervous system	0.674	0.326
D42 Neoplasm of uncertain or unknown behaviour of meninges	0.674	0.326
D40 Neoplasm of uncertain or unknown behaviour of male genital organs	0.674	0.326
D39 Neoplasm of uncertain or unknown behaviour of female genital organs	0.674	0.326
N28.9 Disorder of kidney and ureter, unspecified	0.674	0.326
A09.0 Other and unspecified gastroenteritis and colitis of infectious origin	0.673	0.327
Q50-Q56 Congenital malformations of genital organs	0.673	0.327
C82.9 Follicular non-Hodgkin's lymphoma, unspecified	0.673	0.327
D33 Benign neoplasm of brain and other parts of central nervous system	0.671	0.329
Z55-Z65 Persons with potential health hazards related to socioeconomic and psychosocial circumstances	0.671	0.329
T84.8 Other complications of internal orthopaedic prosthetic devices, implants and grafts	0.670	0.330
Z51.2 Other chemotherapy	0.669	0.331
N07 Hereditary nephropathy, not elsewhere classified	0.669	0.331
N06 Isolated proteinuria with specified morphological lesion	0.669	0.331
N05 Unspecified nephritic syndrome	0.669	0.331
N04 Nephrotic syndrome	0.669	0.331
N01 Rapidly progressive nephritic syndrome	0.669	0.331
N00 Acute nephritic syndrome	0.669	0.331
N17.0 Acute renal failure with tubular necrosis	0.668	0.332
C50.5 Lower-outer quadrant of breast	0.668	0.332
N51 Disorders of male genital organs in diseases classified elsewhere	0.667	0.333
N49 Inflammatory disorders of male genital organs, not elsewhere classified	0.667	0.333
N46 Male infertility	0.667	0.333
N44 Torsion of testis	0.667	0.333
U82-U85 Resistance to antimicrobial and antineoplastic drugs	0.666	0.333
Z52 Donors of organs and tissues	0.666	0.334
N60-N64 Disorders of breast	0.666	0.334
M40-M43 Deforming dorsopathies	0.665	0.334
C77.4 Inguinal and lower limb lymph nodes	0.665	0.335
T82.8 Other complications of cardiac and vascular prosthetic devices, implants and grafts	0.665	0.335
Q90-Q99 Chromosomal abnormalities, not elsewhere classified	0.665	0.335
Q35-Q37 Cleft lip and cleft palate	0.665	0.335
Q30-Q34 Congenital malformations of the respiratory system	0.665	0.335
Q10-Q18 Congenital malformations of eye, ear, face and neck	0.665	0.335
Q00-Q07 Congenital malformations of the nervous system	0.665	0.335
M84 Disorders of continuity of bone	0.663	0.337
Z92.3 Personal history of irradiation	0.663	0.337
D17.5 Benign lipomatous neoplasm of intra-abdominal organs	0.661	0.338
E89 Postprocedural endocrine and metabolic disorders, not elsewhere classified	0.661	0.339
Y57 Other and unspecified drugs and medicaments	0.660	0.340
E15-E16 Other disorders of glucose regulation and pancreatic internal secretion	0.660	0.340
C67.9 Bladder, unspecified	0.659	0.341
Z45.9 Adjustment and management of unspecified implanted device	0.658	0.341
Z45.3 Adjustment and management of implanted hearing device	0.658	0.341
T82.7 Infection and inflammatory reaction due to other cardiac and vascular devices, implants and grafts	0.658	0.342
A08 Viral and other specified intestinal infections	0.657	0.343
M05-M14 Inflammatory polyarthropathies	0.657	0.343
N42.9 Disorder of prostate, unspecified	0.656	0.344
C18 Malignant neoplasm of colon	0.656	0.344
B34.9 Viral infection, unspecified	0.655	0.345
C68 Malignant neoplasm of other and unspecified urinary organs	0.655	0.345
C66 Malignant neoplasm of ureter	0.655	0.345
C65 Malignant neoplasm of renal pelvis	0.655	0.345
O99 Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium	0.654	0.346
S29 Other and unspecified injuries of thorax	0.654	0.346
Y59 Other and unspecified vaccines and biological substances	0.653	0.347
Y58 Bacterial vaccines	0.653	0.347
Y56 Topical agents primarily affecting skin and mucous membrane and ophthalmological, otorhinolaryngological and dental drugs	0.653	0.347
Y55 Agents primarily acting on smooth and skeletal muscles and the respiratory system	0.653	0.347
Y54 Agents primarily affecting water-balance and mineral and uric acid metabolism	0.653	0.347
Y53 Agents primarily affecting the gastro-intestinal system	0.653	0.347
Y52 Agents primarily affecting the cardiovascular system	0.653	0.347
Y50 Central nervous system stimulants, not elsewhere classified	0.653	0.347
Y49 Psychotropic drugs, not elsewhere classified	0.653	0.347
Y48 Anaesthetics and therapeutic gases	0.653	0.347
Y47 Sedatives, hypnotics and antianxiety drugs	0.653	0.347
Y46 Antiepileptics and anti-Parkinsonism drugs	0.653	0.347
C79.3 Secondary malignant neoplasm of brain and cerebral meninges	0.653	0.347
C80.9 Malignant neoplasm, unspecified	0.653	0.347
D10.3 Other and unspecified parts of mouth	0.651	0.349
C56 Malignant neoplasm of ovary	0.651	0.349
N28.1 Cyst of kidney, acquired	0.651	0.349
Z43.1 Attention to gastrostomy	0.651	0.349
Y43.1 Antineoplastic antimetabolites	0.650	0.350
C71 Malignant neoplasm of brain	0.650	0.350
Y60-Y69 Misadventures to patients during surgical and medical care	0.650	0.350
Z73 Problems related to life-management difficulty	0.647	0.353
M65.4 Radial styloid tenosynovitis [de Quervain]	0.647	0.353
M65.2 Calcific tendinitis	0.647	0.353
M65.1 Other infective (teno)synovitis	0.647	0.353
M65.0 Abscess of tendon sheath	0.647	0.353
B35-B49 Mycoses	0.647	0.353
D03 Melanoma in situ	0.646	0.354
E88 Other metabolic disorders	0.646	0.354
E85 Amyloidosis	0.646	0.354
E84 Cystic fibrosis	0.646	0.354
E79 Disorders of purine and pyrimidine metabolism	0.646	0.354
E77 Disorders of glycoprotein metabolism	0.646	0.354
E76 Disorders of glycosaminoglycan metabolism	0.646	0.354
E75 Disorders of sphingolipid metabolism and other lipid storage disorders	0.646	0.354
E74 Other disorders of carbohydrate metabolism	0.646	0.354
E73 Lactose intolerance	0.646	0.354
E72 Other disorders of amino-acid metabolism	0.646	0.354
E71 Disorders of branched-chain amino-acid metabolism and fatty-acid metabolism	0.646	0.354
E70 Disorders of aromatic amino-acid metabolism	0.646	0.354
E90 Nutritional and metabolic disorders in diseases classified elsewhere	0.646	0.354
Z50.5 Speech therapy	0.646	0.354
D68 Other coagulation defects	0.645	0.355
N42.2 Atrophy of prostate	0.645	0.355
Chapter XII Diseases of the skin and subcutaneous tissue	0.645	0.355
C79.6 Secondary malignant neoplasm of ovary	0.644	0.356
C79.4 Secondary malignant neoplasm of other and unspecified parts of nervous system	0.644	0.356
C79.1 Secondary malignant neoplasm of bladder and other and unspecified urinary organs	0.644	0.356
C79.0 Secondary malignant neoplasm of kidney and renal pelvis	0.644	0.356
D36 Benign neoplasm of other and unspecified sites	0.644	0.356
D04.7 Skin of lower limb, including hip	0.644	0.356
Z87.4 Personal history of diseases of the genito-urinary system	0.643	0.357
Z50.2 Alcohol rehabilitation	0.642	0.358
Z50.8 Care involving use of rehabilitation procedures	0.642	0.358
D04.3 Skin of other and unspecified parts of face	0.640	0.360
D07.1 Vulva	0.640	0.360
E87 Other disorders of fluid, electrolyte and acid-base balance	0.638	0.362
E80 Disorders of porphyrin and bilirubin metabolism	0.638	0.362
N41.8 Other inflammatory diseases of prostate	0.638	0.362
N41.3 Prostatocystitis	0.638	0.362
N41.2 Abscess of prostate	0.638	0.362
N41.0 Acute prostatitis	0.638	0.362
M23.87 Other internal derangements of knee (Capsular ligament)	0.638	0.362
M23.86 Other internal derangements of knee (Other and unspecified lateral meniscus)	0.638	0.362

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations